Victory Capital Management Inc. acquired a new stake in shares of biote Corp. (NASDAQ:BTMD – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 18,945 shares of the company’s stock, valued at approximately $106,000.
A number of other hedge funds also recently made changes to their positions in the stock. Allspring Global Investments Holdings LLC purchased a new stake in biote during the second quarter valued at about $42,000. The Manufacturers Life Insurance Company bought a new position in shares of biote during the 2nd quarter valued at about $84,000. Bailard Inc. purchased a new position in shares of biote during the 2nd quarter valued at about $146,000. Rhumbline Advisers raised its holdings in shares of biote by 104.2% during the 2nd quarter. Rhumbline Advisers now owns 28,225 shares of the company’s stock valued at $211,000 after buying an additional 14,404 shares in the last quarter. Finally, WINTON GROUP Ltd lifted its position in biote by 7.0% in the 2nd quarter. WINTON GROUP Ltd now owns 47,725 shares of the company’s stock worth $357,000 after buying an additional 3,124 shares during the last quarter. 21.68% of the stock is owned by institutional investors.
biote Price Performance
Shares of NASDAQ BTMD opened at $6.61 on Monday. The stock has a market capitalization of $359.19 million, a P/E ratio of 25.42 and a beta of 0.94. biote Corp. has a one year low of $3.65 and a one year high of $8.44. The firm’s 50 day simple moving average is $5.59 and its two-hundred day simple moving average is $6.31.
biote Profile
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support.
Featured Stories
- Five stocks we like better than biote
- EV Stocks and How to Profit from Them
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- Investing In Automotive Stocks
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- Want to Profit on the Downtrend? Downtrends, Explained.
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Want to see what other hedge funds are holding BTMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for biote Corp. (NASDAQ:BTMD – Free Report).
Receive News & Ratings for biote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for biote and related companies with MarketBeat.com's FREE daily email newsletter.